<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36411469</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecular brain</Title><ISOAbbreviation>Mol Brain</ISOAbbreviation></Journal><ArticleTitle>Reduced oxidative stress suppresses neurotoxicity in the Drosophila model of TAF15-associated proteinopathies.</ArticleTitle><Pagination><StartPage>93</StartPage><MedlinePgn>93</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">93</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13041-022-00979-8</ELocationID><Abstract><AbstractText>TATA-binding protein associated factor 15 (TAF15) is involved in the pathology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TAF15 accumulates as cytoplasmic aggregates in neurons and the clearance of aggregates may be a therapeutic strategy for ALS, the underlying mechanisms of TAF15 in ALS remain poorly understood. Recently, we found that glutathione transferase omega 2 (GstO2) expression level is significantly reduced in the brain tissue of TAF15-expressing flies. In this study, we demonstrated that GstO2 overexpression in TAF15-induced flies rescues the locomotive activity and neuromuscular junctional defects. Furthermore, TAF15 levels in both cytoplasm and nuclear fractions significantly decreased in the heads of GstO2 co-expressing flies. GstO2-co-overexpression in neurons caused a marked decrease in intracellular reactive oxygen species generation in TAF15-induced flies. Our findings demonstrated that GstO2 was a pathogenic regulator of TAF15-associated proteinopathies. They help expand our understanding of TAF15-associated ALS pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yeo Jeong</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, 31538, Asan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kiyoung</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4879-5207</Identifier><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, 31538, Asan, Korea. kiyoung2@sch.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Brain</MedlineTA><NlmUniqueID>101468876</NlmUniqueID><ISSNLinking>1756-6606</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035381">TATA-Binding Protein Associated Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035381" MajorTopicYN="Y">TATA-Binding Protein Associated Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="Y">Drosophila Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drosophila</Keyword><Keyword MajorTopicYN="N">Glutathione transferase</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Proteinopathies</Keyword><Keyword MajorTopicYN="N">TAF15</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36411469</ArticleId><ArticleId IdType="pmc">PMC9677661</ArticleId><ArticleId IdType="doi">10.1186/s13041-022-00979-8</ArticleId><ArticleId IdType="pii">10.1186/s13041-022-00979-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688&#x2013;700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A. 2011;108(52):20881&#x2013;90. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(3):285&#x2013;90. doi: 10.1002/ajmg.b.31158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.31158</ArticleId><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha SJ, Lee S, Choi HJ, Han YJ, Jeon YM, Jo M, et al. Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models. Dev Cell. 2022;57(6):783&#x2013;98. doi: 10.1016/j.devcel.2022.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2022.02.022</ArticleId><ArticleId IdType="pubmed">35320731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51&#x2013;88. doi: 10.1146/annurev.pharmtox.45.120403.095857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pharmtox.45.120403.095857</ArticleId><ArticleId IdType="pubmed">15822171</ArticleId></ArticleIdList></Reference><Reference><Citation>Burmeister C, Luersen K, Heinick A, Hussein A, Domagalski M, Walter RD, et al. Oxidative stress in Caenorhabditis elegans: protective effects of the Omega class glutathione transferase (GSTO-1) FASEB J. 2008;22(2):343&#x2013;54. doi: 10.1096/fj.06-7426com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-7426com</ArticleId><ArticleId IdType="pubmed">17901115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Lim IA, Kang GU, Cha SJ, Altanbyek V, Kim HJ, et al. Protective effect of Drosophila glutathione transferase omega 1 against hydrogen peroxide-induced neuronal toxicity. Gene. 2015;568(2):203&#x2013;10. doi: 10.1016/j.gene.2015.05.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.05.058</ArticleId><ArticleId IdType="pubmed">26024591</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon D, Coll R, O&#x2019;Neill LA, Board PG. GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway. J Cell Sci. 2015;128(10):1982&#x2013;90. doi: 10.1242/jcs.167858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.167858</ArticleId><ArticleId IdType="pubmed">25908843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim HJ, Cha SJ, Choi HJ, Kim H, Lee S, et al. Genetic activation of parkin rescues TAF15-induced neurotoxicity in a Drosophila model of amyotrophic lateral sclerosis. Neurobiol Aging. 2019;73:68&#x2013;73. doi: 10.1016/j.neurobiolaging.2018.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.023</ArticleId><ArticleId IdType="pubmed">30339961</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HJ, Joo Cha S, Do HA, Kim HJ, Lee JW, Kim K. SCF-Slimb is critical for Glycogen synthase kinase-3beta-mediated suppression of TAF15-induced neurotoxicity in Drosophila. J Neurochem. 2021;157(6):2119&#x2013;27. doi: 10.1111/jnc.15182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15182</ArticleId><ArticleId IdType="pubmed">32915460</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;65:509&#x2013;27. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala V, Granado-Serrano AB, Cacabelos D, Naudi A, Ilieva EV, Boada J, et al. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS. Acta Neuropathol. 2011;122(3):259&#x2013;70. doi: 10.1007/s00401-011-0850-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0850-y</ArticleId><ArticleId IdType="pubmed">21706176</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134(Pt 9):2595&#x2013;609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>